223 13F filers hold it · −17 against the quarter before · shares held +2.0%
Holdings of 06/30
StocksIs Wall Street adding or cutting?−17 Who bought more than 5%?5.8%
All insider trades in GeneDx Holdings
All planned sales of GeneDx Holdings
GeneDx Holdings WGS
Health care sectorNasdaq
What to see in GeneDx Holdings now
Goldman Sachs Group holds 5.8% · +1.9pp on the report before
Filed 08/11
Company
- Exchange
- Nasdaq
- Sector
- Health care
- Industry
- Services-Health Services
- Headquarters
- Stamford, Connecticut
- Fiscal year end
- 12/31
- Next earnings
- 10/18, estimated
Insider trades
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
Katherine StuelandCHIEF EXECUTIVE OFFICER | Open-market sale | 06/16 | 06/18 | 2,140 sh | $59.75 | $127,865 | −1.9% |
Kevin FeeleyCHIEF FINANCIAL OFFICER | Open-market sale | 06/16 | 06/18 | 760 sh | $59.75 | $45,410 | −1.7% |
Katherine StuelandCHIEF EXECUTIVE OFFICER | Open-market sale | 06/16 | 06/18 | 5,932 sh | $60.83 | $360,843.56 | −5.3% |
Kevin FeeleyCHIEF FINANCIAL OFFICER | Open-market sale | 06/16 | 06/18 | 2,106 sh | $60.83 | $128,107.98 | −4.9% |
Katherine StuelandCHIEF EXECUTIVE OFFICER | Open-market sale | 06/16 | 06/18 | 2,429 sh | $61.50 | $149,383.5 | −2.3% |
Planned sales
Feeley KevinOfficer | GeneDx HoldingsWGS | 5,410 sh | $458,500 | 09/01 | Filed 09/01 |
Stueland KatherineOfficer, Director | GeneDx HoldingsWGS | 14,243 sh | $1,208,100 | 09/09 | Filed 09/01 |
Feeley KevinOfficer | GeneDx HoldingsWGS | 5,804 sh | $366,000 | 04/29 | Filed 04/29 |
Stueland KatherineDirector, Officer | GeneDx HoldingsWGS | 16,415 sh | $1,037,500 | 04/29 | Filed 04/29 |
Bryan DechairoOfficer | GeneDx HoldingsWGS10b5-1 plan | 9,374 sh | $929,900 | 02/02 | Filed 02/02 |
Feeley KevinOfficer | GeneDx HoldingsWGS | 24,155 sh | $2,369,700 | 01/29 | Filed 01/29 |
Stueland KatherineOfficer, Director | GeneDx HoldingsWGS | 94,495 sh | $9,268,700 | 01/29 | Filed 01/29 |
Joshua RuchDirector | GeneDx HoldingsWGS | 38,000 sh | $6,093,969 | 25/11/24 | Filed 25/11/24 |
Feeley KevinOfficer | GeneDx HoldingsWGS10b5-1 plan | 5,805 sh | $625,400 | 25/09/30 | Filed 25/09/30 |
Feeley KevinOfficer | GeneDx HoldingsWGS10b5-1 plan | 6,609 sh | $716,260 | 25/09/30 | Filed 25/09/30 |